Phase II studies of AZD1775, a WEE1 kinase inhibitor, and...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

Phase II studies of AZD1775, a WEE1 kinase inhibitor, and chemotherapy in non-small-cell lung cancer (NSCLC): Lead-in cohort results

Spigel, D.R., Dakhil, S., Beck, J.T., Sadiq, A., Menon, S., Webb, C.D., Tsai, F.Y., Johnson, M., Jones, S.F., Greenlees, C., Stults, D.M., Strickland, D., Cook, C., Mugundu, G.M., Laing, N.M., French,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw368.22
Date:
October, 2016
File:
PDF, 42 KB
english, 2016
Conversion to is in progress
Conversion to is failed